An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

331

Participants

Timeline

Start Date

November 23, 2006

Primary Completion Date

July 31, 2009

Study Completion Date

July 26, 2024

Conditions
Thyroid Cancer
Interventions
DRUG

ZD6474 (Vandetanib)

once daily oral tablet

Trial Locations (127)

1000

Investigational Site Number 1101, Brussels

1070

Investigational Site Number : 1101, Anderlecht

1901

Investigational Site Number 1901, Vienna

Investigational Site Number : 1901, Vienna

2065

Investigational Site Number 1001, St Leonards

3000

Investigational Site Number 1102, Leuven

Investigational Site Number : 1102, Leuven

4031

Investigational Site Number 2101, Basel

Investigational Site Number : 2101, Basel

5000

Investigational Site Number 2701, Odense C

Investigational Site Number : 2701, Odense C

7624

Investigational Site Number 1601, Pécs

Investigational Site Number : 1601, Pécs

11000

Investigational Site Number 3401, Belgrade

Investigational Site Number : 3401, Belgrade

14000

Investigational Site Number 2402, Mexico City

15006

Investigational Site Number 3601, Prague

Investigational Site Number : 3601, Prague

17176

Investigational Site Number 3102, Stockholm

Investigational Site Number : 3102, Stockholm

28040

Investigational Site Number 3003, Madrid

Investigational Site Number : 3003, Madrid

28041

Investigational Site Number 3001, Madrid

Investigational Site Number : 3001, Madrid

29425

Investigational Site Number 19, Charleston

Medical University of South Carolina- Site Number : 19, Charleston

31008

Investigational Site Number : 3002, Pamplona

Investigational Site Number 3002, Pamplona

32224

Investigational Site Number 15, Jacksonville

Mayo Clinic- Site Number : 15, Jacksonville

33076

Investigational Site Number 2802, Bordeaux

Investigational Site Number : 2802, Bordeaux

45122

Investigational Site Number 2002, Essen

Investigational Site Number : 2002, Essen

48201

Investigational Site Number 7, Detroit

Wayne State University / Harper Hospital Site Number : 7, Detroit

53100

Investigational Site Number 2504, Siena

Investigational Site Number : 2504, Siena

55905

Investigational Site Number 14, Rochester

Mayo Clinic- Site Number : 14, Rochester

56124

Investigational Site Number 2501, Pisa

Investigational Site Number : 2501, Pisa

60637

Investigational Site Number 18, Chicago

The University Of Chicago Site Number : 18, Chicago

63110

Investigational Site Number 10, St Louis

Washington University School Of Med Site Number : 10, St Louis

69373

Investigational Site Number 2803, Lyon

Investigational Site Number : 2803, Lyon

72205

Investigational Site Number 3, Little Rock

University Arkansas Site Number : 3, Little Rock

75185

Investigational Site Number 3101, Uppsala

Investigational Site Number : 3101, Uppsala

77030

Anderson Cancer Center Site Number : 13, Houston

Investigational Site Number 13, Houston

80010

Investigational Site Number 9, Aurora

University Of Colorado Health Sciences Center Site Number : 9, Aurora

80131

Investigational Site Number 2503, Napoli

Investigational Site Number : 2503, Napoli

94115

Investigational Site Number 8, San Francisco

USCF / Mt Zion Medical Center Site Number : 8, San Francisco

94800

Investigational Site Number 2801, Villejuif

Investigational Site Number : 2801, Villejuif

97080

Investigational Site Number 2005, Würzburg

Investigational Site Number : 2005, Würzburg

97239

Investigational Site Number 22, Portland

Oregon Health & Science University- Site Number : 22, Portland

249036

Investigational Site Number 3301, Obninsk

Investigational Site Number : 3301, Obninsk

400012

Investigational Site Number 1401, Mumbai

Investigational Site Number : 1401, Mumbai

632004

Investigational Site Number 1402, Vellore

Investigational Site Number : 1402, Vellore

06510

Investigational Site Number 11, New Haven

Yale University School Medicine Site Number : 11, New Haven

40536-0298

Investigational Site Number 17, Lexington

The University Of Kentucky Site Number : 17, Lexington

02115

Dana Farber Cancer Institute Site Number : 2, Boston

Investigational Site Number 2, Boston

45267-0589

Investigational Site Number 6, Cincinnati

University Of Cincinnati Site Number : 6, Cincinnati

05401

Fletcher Allen Health Care Site Number : 21, Burlington

Investigational Site Number 21, Burlington

90035-003

Hospital De Clinicas De Porto Alegre- Site Number : 2301, Porto Alegre

Investigational Site Number 2301, Porto Alegre

14048-900

Faculdade de Medicina de Ribeirao Preto - USP- Site Number : 2302, Ribeirão Preto

Investigational Site Number 2302, Ribeirão Preto

T2E7C5

Investigational Site Number : 1203, Calgary

Investigational Site Number 1203, Calgary

E1C6Z8

Investigational Site Number : 1201, Moncton

Investigational Site Number 1201, Moncton

N6A 4L6

Investigational Site Number : 1202, London

Investigational Site Number 1202, London

M5G2M9

Investigational Site Number : 1205, Toronto

Investigational Site Number 1205, Toronto

J1H 5N4

Investigational Site Number : 1204, Sherbrooke

Investigational Site Number 1204, Sherbrooke

06120

Investigational Site Number 2001, Halle

Investigational Site Number : 2001, Halle

Unknown

Investigational Site Number 2506, Catania

Investigational Site Number : 2506, Catania

Investigational Site Number 2502, Milan

Investigational Site Number : 2502, Milan

Investigational Site Number 2403, Ciudad Madero

Investigational Site Number 2902, Groningen

Investigational Site Number : 2902, Groningen

Investigational Site Number 2901, Utrecht

Investigational Site Number : 2901, Utrecht

Investigational Site Number 1801, Bucharest

Investigational Site Number 3402, Belgrade

Investigational Site Number : 3402, Belgrade

Investigational Site Number 1501, Seoul

00161

Investigational Site Number 2505, Roma

Investigational Site Number : 2505, Roma

06726

Investigational Site Number 2404, México

Investigational Site Number : 2404, México

60-355

Investigational Site Number : 1702, Poznan

Investigational Site Number 1702, Poznan

02-781

Investigational Site Number : 1703, Warsaw

Investigational Site Number 1703, Warsaw

44-101

Investigational Site Number 1701, Gliwice

Investigational Site Number : 1701, Gliwice

3000-75

Investigational Site Number 2602, Coimbra

1099-023

Investigational Site Number 2601, Lisbon

Investigational Site Number : 2601, Lisbon

03080

Investigational Site Number : 1501, Seoul

CH-3010

Investigational Site Number 2102, Bern

Investigational Site Number : 2102, Bern

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00410761 - An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer | Biotech Hunter | Biotech Hunter